Pneumothorax historical perspective: Difference between revisions
Jump to navigation
Jump to search
m (Categories) |
Usama Talib (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Historical Perspective== | ==Historical Perspective== | ||
| Line 9: | Line 8: | ||
Prior to the advent of anti tuberculous medications, iatrogenic pneumothoraces were intentionally given to tuberculosis patients in an effort to collapse a lobe, or entire lung around a cavitating lesion. This was known as 'resting the lung' . | Prior to the advent of anti tuberculous medications, iatrogenic pneumothoraces were intentionally given to tuberculosis patients in an effort to collapse a lobe, or entire lung around a cavitating lesion. This was known as 'resting the lung' . | ||
==Overview== | |||
==Historical Perspective== | |||
===Discovery=== | |||
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event]. | |||
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event]. | |||
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name]. | |||
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name]. | |||
==Outbreaks== | |||
*There have been several outbreaks of [disease name], which are summarized below: | |||
==Landmark Events in the Development of Treatment Strategies== | |||
*In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name]. | |||
==Impact on Cultural History== | |||
==Famous Cases== | |||
*The following are a few famous cases of [[disease name]]: | |||
ategory: (name of the system)]] | |||
== References == | == References == | ||
Revision as of 17:10, 4 February 2018
|
Pneumothorax Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pneumothorax historical perspective On the Web |
|
American Roentgen Ray Society Images of Pneumothorax historical perspective |
|
Risk calculators and risk factors for Pneumothorax historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Historical Perspective
Jean Marc Gaspard Itard, a student of Rene Laennec, first recognised pneumothorax in 1803, and Laennec himself described the full clinical picture in 1819[1].
Prior to the advent of anti tuberculous medications, iatrogenic pneumothoraces were intentionally given to tuberculosis patients in an effort to collapse a lobe, or entire lung around a cavitating lesion. This was known as 'resting the lung' .
Overview
Historical Perspective
Discovery
- [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
Outbreaks
- There have been several outbreaks of [disease name], which are summarized below:
Landmark Events in the Development of Treatment Strategies
- In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
Impact on Cultural History
Famous Cases
- The following are a few famous cases of disease name:
ategory: (name of the system)]]
References
- ↑ Laennec RTH. Traite de l'auscultation mediate et des maladies des poumons et du coeur. Part II. Paris, 1819.